— Know what they know.
Not Investment Advice

ZRO.CN CNQ

Biosenta Inc.
1W: -11.1% 1M: +45.5% 3M: +60.0% YTD: +0.0% 1Y: -40.7% 3Y: -65.2% 5Y: -89.2%
C$0.08 ($0.06)
+0.04 (+100.00%)
 
CNQ · Consumer Defensive · Household & Personal Products · Tech Score Buy · Power 67 · C$2.8M mcap · 18M float · 0.045% daily turnover

Balance Sheet Trends

Total Assets
$110K -2.8% ▼
5Y CAGR: +0.3%
Total Liabilities
$10M +27.3% ▲
5Y CAGR: +38.8%
Shareholders Equity
-$10M -27.8% ▼
Cash & Investments
$26K +210.6% ▲
5Y CAGR: -9.8%
Total Debt
$695K -87.5% ▼
5Y CAGR: +59.4%
Net Debt
$668K -87.9% ▼

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2021FY2022FY2023FY2024FY2025
— Assets —
Cash$112K$27K$6K$9K$26K
Short-Term Investments$0$0$0$0$0
Cash & ST Investments$112K$27K$6K$9K$26K
Net Receivables$3K$145K$20K$46K$10K
Inventory$77K$45K$40K$38K$37K
Other Current Assets$0$0$0$0$0
Total Current Assets$264K$262K$92K$101K$74K
Property, Plant & Equip.$0$0$16K$13K$36K
Goodwill & Intangibles$0$0$0$0$0
Long-Term Investments$0$0$0$0$0
Other Non-Current Assets$0$0$0$0$0
Total Non-Current Assets$0$0$16K$13K$36K
Total Assets$264K$256K$108K$114K$110K
— Liabilities —
Accounts Payable$575K$753K$1M$1M$1M
Short-Term Debt$92K$35K$323K$97K$635K
Deferred Revenue$0$0$0$0$0
Other Current Liabilities$1M$2M$254K$0$8M
Total Current Liabilities$3M$3M$3M$3M$10M
Long-Term Debt$60K$60K$5M$5M$60K
Other Non-Current Liab.$0$0$0$0$0
Total Non-Current Liabilities$60K$60K$5M$5M$60K
Total Liabilities$3M$3M$8M$8M$10M
— Equity —
Common Stock$10M$12M$13M$15M$15M
Retained Earnings-$13M-$15M-$21M-$23M-$26M
Accumulated OCI$841K$953K-$36K$572K$158K
Total Stockholders Equity-$3M-$3M-$8M-$8M-$10M
Total Liabilities & Equity$264K$256K$108K$114K$110K
— Key Metrics —
Total Debt$152K$95K$6M$6M$695K
Net Debt$41K$68K$6M$6M$668K
Total Investments$0$0$0$0$0

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms